U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-Infective, Endocrinology), And Segment Forecasts, 2024 - 2030

Market Segmentation

• U.S. Home Infusion Therapy Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Infusion pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors
• U.S. Home Infusion Therapy Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Anti-Infective
    • Diabetes
    • Others
  • Endocrinology
  • Hydration Therapy
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

U.S. Home Infusion Therapy Market Dynamics

Driver: Increasing Geriatric Population

 Aging is one of the leading risk factors for developing infections and associated complications. Thus, the rapidly aging U.S. population is anticipated to drive market growth. For instance, according to the U.S. Census Bureau, nearly 77.0 million people in the U.S. will be aged 65 & above by 2034 and this number is estimated to reach 94.7 million by 2060 (from 49.2 million in 2016). Furthermore, the increasing preference of elderly people to opt for healthcare services at home is expected to significantly boost the demand for home infusion therapy products & services during the forecast period. For instance, according to AARP, in 2018, nearly 76% of individuals in the U.S. aged 50 & above preferred to stay in their current residence. In addition, a study published in Open Forum Infectious Diseases, with median patients aged 60 & above, demonstrated higher patient satisfaction for outpatient parenteral antibiotic therapy delivered at home as compared to nursing facilities. Thus, high patient satisfaction with home care is anticipated to fuel market growth.

Driver: Rising Prevalence Of Chronic Disorders

According to WHO, currently, chronic diseases such as respiratory disorders, diabetes, cancer, cardiovascular diseases, and other life-threatening diseases account for ~60% of the total number of deaths and 43% of the global burden of diseases. These percentages are likely to increase to ~73% and ~60%, respectively, by 2020. Moreover, the rising prevalence of diabetes, which requires sustained and daily doses of insulin, is expected to contribute to market growth. For instance, According to the IDF, the number of people suffering from diabetes is expected to increase from around 31 million in 2019 to around 34.4 million by 2030 in the U.S. The high prevalence of diabetes is expected to positively impact the market, especially in the U.S. Home infusion is considered to be a cost-effective alternative to an extended hospital stay or a nursing home placement for patients suffering from chronic diseases Dehydration is becoming common among individuals with sedentary lifestyle. According to an article published by Drip Drop Hydration, nearly 75% of Americans are chronically dehydrated. Dehydration is known to impair cognitive functions and lead to reduced productivity. Moreover, chronic dehydration results in impaired kidney, gastrointestinal, and heart functions. Severe dehydration can also result in death. The high-risk factors associated with dehydration are likely to fuel market growth.

Restraint: Reimbursement Issues

Medicare fee-for-service program (Parts A, B, and D) does not offer adequate coverage for home infusion therapies, thereby reducing the affordability for beneficiaries, especially the elderly and disabled. Although a majority of the infusion drugs are covered under Medicare Part D (Medicare prescription drug benefit program), the Centers for Medicare & Medicaid Services (CMS) does not cover associated services, supplies, and equipment under this category, increasing the financial burden on patients. In addition, Medicare Part B offers coverage for infusion therapies that use durable medical equipment (such as an electronic external infusion pump). However, only selected therapies are covered under this section and even those are required to meet very specific conditions for reimbursement, thereby limiting patient access to affordable care. In addition, according to the National Home Infusion Association, the professional services benefit, covered by the CMS in the Medicare Part B home infusion drugs, requires the physical presence of a nurse at the patient’s home for the provider to be reimbursed. Thus, this could lead to inconvenience for patients in case of the unavailability of nurses, which may limit the adoption of these therapies.

What Does This Report Include?

This section will provide insights into the contents included in this U.S. home infusion therapy market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

U.S. home infusion therapy market qualitative analysis

• Industry overview

• Industry trends

• Market drivers and restraints

• Market size

• Growth prospects

• Porter’s analysis

• PESTEL analysis

• Key market opportunities prioritized

• Competitive landscape

  • Company overview

  • Financial performance

  • Product benchmarking

  • Latest strategic developments

U.S. home infusion therapy market quantitative analysis

• Market size, estimates, and forecast from 2018 to 2030

• Market estimates and forecast for product segments up to 2030

• Regional market size and forecast for product segments up to 2030

• Market estimates and forecast for application segments up to 2030

• Regional market size and forecast for application segments up to 2030

• Company financial performance